Avantor, Inc. (NYSE:AVTR) Shares Bought by Natixis Advisors L.P.

Natixis Advisors L.P. increased its stake in Avantor, Inc. (NYSE:AVTR - Free Report) by 29.8% in the fourth quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 1,744,179 shares of the company's stock after purchasing an additional 400,592 shares during the period. Natixis Advisors L.P. owned 0.26% of Avantor worth $39,818,000 as of its most recent filing with the Securities & Exchange Commission.

Several other large investors also recently bought and sold shares of the stock. Fifth Third Bancorp raised its stake in shares of Avantor by 125.3% in the fourth quarter. Fifth Third Bancorp now owns 1,248 shares of the company's stock worth $28,000 after purchasing an additional 694 shares during the last quarter. Livforsakringsbolaget Skandia Omsesidigt lifted its stake in Avantor by 565.5% during the 4th quarter. Livforsakringsbolaget Skandia Omsesidigt now owns 1,331 shares of the company's stock valued at $30,000 after acquiring an additional 1,131 shares during the period. GAMMA Investing LLC purchased a new stake in shares of Avantor in the 4th quarter valued at $47,000. CKW Financial Group purchased a new stake in shares of Avantor in the 4th quarter valued at $55,000. Finally, ORG Partners LLC acquired a new stake in shares of Avantor in the fourth quarter worth $89,000. Hedge funds and other institutional investors own 95.08% of the company's stock.

Insiders Place Their Bets

In related news, EVP James Bramwell sold 6,203 shares of the business's stock in a transaction dated Tuesday, February 27th. The shares were sold at an average price of $24.49, for a total transaction of $151,911.47. Following the transaction, the executive vice president now directly owns 101,143 shares in the company, valued at $2,476,992.07. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this hyperlink. 1.50% of the stock is currently owned by corporate insiders.

Analyst Upgrades and Downgrades

A number of research analysts recently issued reports on AVTR shares. Citigroup boosted their target price on shares of Avantor from $24.00 to $30.00 and gave the company a "buy" rating in a research report on Thursday, February 15th. Raymond James raised their target price on Avantor from $22.50 to $26.00 and gave the stock an "outperform" rating in a report on Friday, January 26th. Royal Bank of Canada boosted their price target on Avantor from $28.00 to $29.00 and gave the company an "outperform" rating in a report on Thursday, February 15th. Deutsche Bank Aktiengesellschaft raised their price objective on shares of Avantor from $23.00 to $25.00 and gave the stock a "hold" rating in a research note on Thursday, April 18th. Finally, UBS Group boosted their target price on shares of Avantor from $25.00 to $29.00 and gave the company a "buy" rating in a research note on Thursday, February 15th. Four research analysts have rated the stock with a hold rating and twelve have assigned a buy rating to the stock. Based on data from MarketBeat.com, Avantor presently has an average rating of "Moderate Buy" and an average price target of $26.71.

Avantor Price Performance

AVTR stock traded up $0.40 during trading on Friday, hitting $24.72. The stock had a trading volume of 3,436,407 shares, compared to its average volume of 4,975,536. Avantor, Inc. has a twelve month low of $16.63 and a twelve month high of $26.16. The company's 50-day moving average price is $25.09 and its two-hundred day moving average price is $22.72. The company has a debt-to-equity ratio of 0.94, a current ratio of 1.61 and a quick ratio of 1.05. The stock has a market capitalization of $16.79 billion, a P/E ratio of 63.38, a PEG ratio of 1.48 and a beta of 1.36.

Avantor (NYSE:AVTR - Get Free Report) last released its earnings results on Friday, April 26th. The company reported $0.22 earnings per share for the quarter, beating the consensus estimate of $0.20 by $0.02. Avantor had a return on equity of 13.01% and a net margin of 3.79%. The business had revenue of $1.68 billion for the quarter, compared to the consensus estimate of $1.68 billion. During the same quarter last year, the business posted $0.29 earnings per share. The business's quarterly revenue was down 5.6% compared to the same quarter last year. As a group, research analysts predict that Avantor, Inc. will post 1.01 EPS for the current fiscal year.

Avantor Company Profile

Avantor, Inc engages in the provision of mission-critical products and services to customers in the biopharma, healthcare, education and government, advanced technologies, and applied materials industries in the Americas, Europe, Asia, the Middle East, and Africa. The company offers materials and consumables, such as purity chemicals and reagents, lab products and supplies, formulated silicone materials, customized excipients, customized single-use assemblies, process chromatography resins and columns, analytical sample prep kits, education and microbiology products, clinical trial kits, peristaltic pumps, and fluid handling tips.